Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Read more about Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.
Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Read more about Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors. Read more about Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. Read more about Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study. Read more about Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Biliary cancer: Utility of next-generation sequencing for clinical management. Read more about Biliary cancer: Utility of next-generation sequencing for clinical management.
Lay health educators increase colorectal cancer screening among Hmong Americans: A cluster randomized controlled trial. Read more about Lay health educators increase colorectal cancer screening among Hmong Americans: A cluster randomized controlled trial.
The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Read more about The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies. Read more about Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients. Read more about The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
